McKinsey Under Criminal Investigation Over Opioid-Related Consulting -- WSJ
By Alexander Gladstone The Justice Department is conducting a criminal investigation into consulting firm McKinsey related to its past role in advising some of the nation's largest opioid manufacture
WSJApr 24 15:04 ET
Endo Has Started Process of Listing Its Equity on a National Stock Exchange
Endo Has Started Process of Listing Its Equity on a National Stock Exchange
Dow JonesApr 23 16:50 ET
Endo Inc. Completes Acquisition of Endo Intl's Assets
Endo Inc. Completes Acquisition of Endo Intl's Assets
Dow JonesApr 23 16:49 ET
Express News | Endo International- Par Pharmaceutical Expanding Voluntary Recall to Include 7 Lots of Treprostinil Injection 20Mg/20Ml (1Mg/Ml) to Consumer Level
Moomoo 24/7Apr 22 07:58 ET
Express News | Par Pharmaceutical Issues Voluntary Nationwide Recall of Seven Lots of Treprostinil Injection Due to Potential for Silicone Particulates in the Product Solution
Moomoo 24/7Apr 22 07:57 ET
Express News | Endo International: Endo Companies Are Not Selling, Buyers Are Not Purchasing, Any Assets Other Than Transferred Assets
Moomoo 24/7Apr 18 16:56 ET
Express News | Endo International: on April 14, Co, Some of Debtors Got Into Purchase and Sale Agreement Post Which Buyers to Buy Substantially All Assets of Co
Moomoo 24/7Apr 18 16:56 ET
Express News | Endo International PLC - Wholly-Owned Subsidiary Endo Finance Priced Its $1,500 Mln Senior Secured Seven-Year Term Loan
Moomoo 24/7Apr 11 19:47 ET
Express News | Endo International PLC- Subsidiary Endo Finance Holdings Priced $1 Bln Aggregate Principal Amount of Its 8.500% Senior Secured Notes Due 2031
Moomoo 24/7Apr 11 19:41 ET
Express News | Endo, Inc. Announces Pricing of $1.0 Billion of Senior Secured Notes
Moomoo 24/7Apr 11 19:37 ET
Endo, Inc. Announces Pricing of $1.5 Billion of Senior Secured Term Loan as Part of Endo's $2.5 Billion Exit Financing
MALVERN, Pa., April 11, 2024 /PRNewswire/ -- Endo, Inc. ("Endo"), a newly formed entity, today announced that its wholly-owned subsidiary Endo Finance Holdings, Inc. (the "Borrower") priced its $1,500
Endo InternationalApr 11 00:00 ET
Endo, Inc. Announces Proposed Private Offering of Senior Secured Notes
Part of Endo's $2.5 Billion Exit Financing MALVERN, Pa., April 8, 2024 /PRNewswire/ -- Endo, Inc. ("Endo"), a newly formed entity, today announced that its wholly-owned subsidiary Endo Finance Holdi
PR NewswireApr 8 08:01 ET
Endo, Inc. Announces Proposed New Senior Secured Credit Facilities
MALVERN, PA, April 1, 2024 -- Endo, Inc. ("Endo"), a newly formed entity, today announced that its wholly-owned subsidiary Endo Finance Holdings, Inc. (the "Borrower") intends to enter into new senior
Endo InternationalApr 1 00:00 ET
Endo Launches Ibuprofen-Famotidine Tablets, Generic Version of DUEXIS
DUBLIN, March 26, 2024 /PRNewswire/ -- Endo International plc (OTC: ENDPQ) announced today that one of its operating companies, Par Pharmaceutical, Inc., launched ibuprofen-famotidine 800 mg/26.6 mg t
Endo InternationalMar 26 00:00 ET
Drugmaker Endo Receives US Court Approval for Bankruptcy Restructuring
Yahoo FinanceMar 19 18:42 ET
Endo Gains OK for Chapter 11 Bankruptcy Reorgaanization
Seeking AlphaMar 19 18:31 ET
Endo Expects to Complete Restructuring as Early as Late April
Endo Expects to Complete Restructuring as Early as Late April
Dow JonesMar 19 17:32 ET
Endo Announces Confirmation of Plan of Reorganization
Endo Announces Confirmation of Plan of Reorganization
Dow JonesMar 19 17:31 ET
Par Pharmaceutical Recalls Treprostinil Injection Lot
Endo International (OTC:ENDPQ) plc's subsidiary, Par Pharmaceutical, has initiated a voluntary recall of a specific lot of Treprostinil Injection, used for treating pulmonary arterial hypertension, due to potential contamination with silicone particulates.
Investing.com Mar 12 14:08 ET
Endo to Pay Over $1.45B to Feds to Settle Misbranding Opioid Charge
Seeking AlphaFeb 29 13:46 ET
No Data
No Data